对侧预防性乳房切除术适应证:改良德尔菲法共识声明
该共识采用改良德尔菲法,由19名普通外科医生、2名整形外科医生、2名肿瘤内科医生、2名放射肿瘤医生和1名心理学家组成的专家小组,针对单侧乳腺癌患者对侧预防性乳房切除术(CPM)的适应证形成共识。专家小组不建议平均风险的单侧乳腺癌女性接受CPM,推荐既往接受过斗篷野放疗或携带BRCA1/2基因突变的单侧乳腺癌女性接受CPM,并认为对于携带CHEK2/PTEN/p53/PALB2/CDH1基因突变或单侧乳房切除后难以达到对称性的女性,外科医生可个体化考虑CPM。
要点
- 不推荐平均风险的单侧乳腺癌女性常规接受对侧预防性乳房切除术。
- 既往斗篷野放疗或BRCA1/2突变的单侧乳腺癌女性推荐接受CPM。
- CHEK2/PTEN/p53/PALB2/CDH1突变或对称性困难者可个体化考虑CPM。
核心结论
- 对侧预防性乳房切除术很少推荐用于单侧乳腺癌女性。
研究设计与样本
- 采用改良德尔菲法形成共识声明,专家小组包括19名普通外科医生、2名整形外科医生、2名肿瘤内科医生、2名放射肿瘤医生和1名心理学家。
- 专家组成员采用7点Likert量表对声明进行评分,完成两轮匿名电子评分与反馈后召开面对面会议,共识定义为至少80%同意。
主要发现
- 专家小组不建议平均风险的单侧乳腺癌女性接受对侧预防性乳房切除术。
- 专家小组推荐既往接受过斗篷野放疗或携带BRCA1/2基因突变的单侧乳腺癌女性接受对侧预防性乳房切除术。
- 专家小组同意外科医生可基于个体情况考虑对携带CHEK2/PTEN/p53/PALB2/CDH1基因突变的单侧乳腺癌女性以及单侧乳房切除后可能难以达到对称性的女性实施对侧预防性乳房切除术。
临床怎么用
- 临床决策时应向平均风险的单侧乳腺癌女性说明不推荐常规对侧预防性乳房切除术。
- 对既往斗篷野放疗或BRCA1/2突变的单侧乳腺癌女性,可依据共识推荐讨论对侧预防性乳房切除术。
- 对CHEK2/PTEN/p53/PALB2/CDH1突变或预计对称性困难者,可由外科医生个体化评估对侧预防性乳房切除术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To reach a consensus about contralateral prophylactic mastectomy in unilateral breast cancer. SUMMARY BACKGROUND DATA: There has been a substantial increase in the number of North American women with unilateral breast cancer undergoing a therapeutic mastectomy and a contralateral prophylactic mastectomy (CPM) either simultaneously or sequentially. The purpose of this project was to create a nationally endorsed consensus statement for CPM in women with unilateral breast cancer using modified Delphi consensus methodology. METHODS: A nationally representative expert panel of 19 general surgeons, 2 plastic surgeons, 2 medical oncologists, 2 radiation oncologists, and 1 psychologist was invited to participate in the generation of a consensus statement. Thirty-nine statements were created in 5 topic domains: predisposing risk factors for breast cancer, tumor factors, reconstruction/symmetry issues, patient factors, and miscellaneous factors. Panelists were asked to rate statements on a 7-point Likert scale. Two electronic rounds of iterative rating and feedback were anonymously completed, followed by an in-person meeting. Consensus was reached when there was at least 80% agreement. RESULTS: Our panelists did not recommend for average risk women with unilateral breast cancer. The panel recommended CPM for women with a unilateral breast cancer and previous Mantle field radiation or a BrCa1/2 gene mutation. The panel agreed that CPM could be considered by the surgeon on an individual basis for: women with unilateral breast cancer and a genetic mutation in the CHEK2/PTEN/p53/PALB2/CDH1 gene, and in women who may have significant difficulty achieving symmetry after unilateral mastectomy. CONCLUSION: Contralateral prophylactic mastectomy is rarely recommended for women with unilateral breast cancer.
引用
- Wright FC, Look Hong NJ, Quan ML, et al. Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology. Ann Surg. 2018. PMID: 28594745. doi:10.1097/SLA.0000000000002309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。